Global race for Coronavirus vaccine: Germany buys 23% stake in CureVac

As the world comes to grips with the coronavirus pandemic the country's invest money and resources to push for a vaccine. Germany has taken a 23% stake in a private company and the company is called CureVac. Watch report.